MedNova provides integrated clinical development services — from feasibility and regulatory planning through study close-out — to help sponsors execute with confidence across Nigeria and West Africa.
Every engagement moves through the same sequence — visible to the sponsor at every stage.
We know how Nigeria's health systems actually work — not just how they look on paper.
Participant dignity and safety are the starting point of a study design, not a compliance afterthought.
Built to flex from a single-site pilot to a multi-country program without re-inventing the approach.
Local footing means faster site activation and fewer surprises at the approval stage.
Not a list of departments — the actual phases a clinical development program moves through, from first feasibility question to database lock.
Technology enabled — we use proprietary digital tools to support feasibility assessment and trial execution, with every output reviewed by our clinical team.
Assessing whether a protocol can realistically run at a given site or in a given region — patient population, competing studies, and investigator capacity — before a sponsor commits resources to it.
Evaluating candidate sites against the protocol's actual requirements — staffing, equipment, patient volume, and track record — not just what's on a capability questionnaire.
A structured assessment of whether a site, region, and regulatory pathway are actually ready to support a protocol — feasibility grounded in the realities of the site, not just the paper submission.
Mapping the approval pathway through relevant regulatory authorities and ethics committees early, so submission timing is built into the study plan rather than discovered midway through it.
Moving a qualified site from selection to first-patient-in — contracting, training, and readiness checks completed against an activation timeline built around the actual site.
Site and vendor agreements negotiated and executed in step with activation timelines, so contracting doesn't become the bottleneck holding up a ready site.
Coordinating laboratory, logistics, and other third-party vendors so their timelines stay aligned with the site's own start-up schedule.
Central and local laboratory testing coordinated alongside sourcing, storage, and cold-chain logistics — including import handling for studies bringing product into Nigeria.
Day-to-day management of site performance, timelines, and budget against a single project plan — one team holding both the site-level and study-level view.
Routine and close-out monitoring, source data verification, and CAPA follow-through, tracked consistently across every site in the study.
Recruitment and retention built around the actual population and geography in front of us — informed consent logistics and retention approaches that account for travel distance and community trust-building.
EDC setup, data cleaning, and query resolution built into how data moves from site to database — quality checked at the source, not after the fact.
Final data cleaning, query resolution, and sign-off coordinated across sites to bring the database to lock on schedule.
Site close-out conducted with the same rigor as activation — reconciling records, resolving outstanding queries, and confirming regulatory documentation is complete.
Site files and trial documentation maintained in a state ready for sponsor audit or regulatory inspection at any point — not assembled after a close-out notice arrives.
Ongoing support through reporting and publication-stage requests, including data queries that arise after a site has formally closed.
Direct familiarity with Nigeria's site landscape and health systems — not a template applied from elsewhere.
Site activation timelines built around the actual site and its regulatory pathway, not a generic template.
Regulatory strategy runs alongside operations at every phase — not handled separately, and not just at submission.
GCP compliance and audit readiness built into how the work happens, rather than checked after the fact.
Writing on African clinical development, regulatory strategy, and trial readiness — drawn from the work itself, not general commentary.
On the gap between template planning and what site-level execution actually requires.
Coming soonA practical look at sequencing regulatory and ethics submissions against a real study timeline.
Coming soonWhy feasibility on paper and feasibility on the ground are two different assessments.
Coming soonMedNova Clinical Development is led by a team with hands-on clinical operations and regulatory experience, applied directly to running programs in Nigeria and West Africa — local expertise, regulatory knowledge, and operational execution, held together by one accountable team.
Answer six questions to get an instant readiness score for your planned study in Nigeria or West Africa — a real assessment tool, not a demo.
Whether you're scoping site feasibility or ready to activate — we'd like to hear what you're working on.